Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An overview and a roadmap for artificial intelligence in hematology and oncology.
Rösler W, Altenbuchinger M, Baeßler B, Beissbarth T, Beutel G, Bock R, von Bubnoff N, Eckardt JN, Foersch S, Loeffler CML, Middeke JM, Mueller ML, Oellerich T, Risse B, Scherag A, Schliemann C, Scholz M, Spang R, Thielscher C, Tsoukakis I, Kather JN. Rösler W, et al. Among authors: kather jn. J Cancer Res Clin Oncol. 2023 Aug;149(10):7997-8006. doi: 10.1007/s00432-023-04667-5. Epub 2023 Mar 15. J Cancer Res Clin Oncol. 2023. PMID: 36920563 Free PMC article. Review.
Artificial intelligence in oncology: chances and pitfalls.
Kather JN. Kather JN. J Cancer Res Clin Oncol. 2023 Aug;149(10):7995-7996. doi: 10.1007/s00432-023-04666-6. Epub 2023 Mar 15. J Cancer Res Clin Oncol. 2023. PMID: 36920564 Free PMC article. Review.
Large Language Models in Uro-oncology.
Ferber D, Kather JN. Ferber D, et al. Among authors: kather jn. Eur Urol Oncol. 2024 Feb;7(1):157-159. doi: 10.1016/j.euo.2023.09.019. Epub 2023 Oct 14. Eur Urol Oncol. 2024. PMID: 37839981 No abstract available.
Artificial intelligence for precision medicine in autoimmune liver disease.
Gerussi A, Scaravaglio M, Cristoferi L, Verda D, Milani C, De Bernardi E, Ippolito D, Asselta R, Invernizzi P, Kather JN, Carbone M. Gerussi A, et al. Among authors: kather jn. Front Immunol. 2022 Nov 11;13:966329. doi: 10.3389/fimmu.2022.966329. eCollection 2022. Front Immunol. 2022. PMID: 36439097 Free PMC article. Review.
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review.
Prelaj A, Miskovic V, Zanitti M, Trovo F, Genova C, Viscardi G, Rebuzzi SE, Mazzeo L, Provenzano L, Kosta S, Favali M, Spagnoletti A, Castelo-Branco L, Dolezal J, Pearson AT, Lo Russo G, Proto C, Ganzinelli M, Giani C, Ambrosini E, Turajlic S, Au L, Koopman M, Delaloge S, Kather JN, de Braud F, Garassino MC, Pentheroudakis G, Spencer C, Pedrocchi ALG. Prelaj A, et al. Among authors: kather jn. Ann Oncol. 2024 Jan;35(1):29-65. doi: 10.1016/j.annonc.2023.10.125. Epub 2023 Oct 23. Ann Oncol. 2024. PMID: 37879443 Review.
How AI will transform cancer care.
Kather JN, Abernethy AP. Kather JN, et al. Ann Oncol. 2024 Sep 15:S0923-7534(24)03915-2. doi: 10.1016/j.annonc.2024.08.2335. Online ahead of print. Ann Oncol. 2024. PMID: 39288845 No abstract available.
197 results